- Home
- MRKR vs ELSE Comparison
MRKR vs ELSE Comparison
Compare MRKR & ELSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- ELSE
- Stock Information
- Founded
- MRKR N/A
- ELSE 1968
- Country
- MRKR United States
- ELSE United States
- Employees
- MRKR N/A
- ELSE N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- ELSE Industrial Machinery/Components
- Sector
- MRKR Health Care
- ELSE Industrials
- Exchange
- MRKR Nasdaq
- ELSE Nasdaq
- Market Cap
- MRKR 16.1M
- ELSE 16.2M
- IPO Year
- MRKR N/A
- ELSE N/A
- Fundamental
- Price
- MRKR $1.18
- ELSE $4.33
- Analyst Decision
- MRKR Strong Buy
- ELSE
- Analyst Count
- MRKR 2
- ELSE 0
- Target Price
- MRKR $13.50
- ELSE N/A
- AVG Volume (30 Days)
- MRKR 239.7K
- ELSE 5.4K
- Earning Date
- MRKR 03-25-2025
- ELSE 03-19-2025
- Dividend Yield
- MRKR N/A
- ELSE N/A
- EPS Growth
- MRKR N/A
- ELSE 29.91
- EPS
- MRKR N/A
- ELSE 0.13
- Revenue
- MRKR $5,395,849.00
- ELSE $9,289,000.00
- Revenue This Year
- MRKR $195.40
- ELSE N/A
- Revenue Next Year
- MRKR N/A
- ELSE N/A
- P/E Ratio
- MRKR N/A
- ELSE $33.66
- Revenue Growth
- MRKR 79.04
- ELSE 11.21
- 52 Week Low
- MRKR $1.13
- ELSE $3.75
- 52 Week High
- MRKR $5.99
- ELSE $5.50
- Technical
- Relative Strength Index (RSI)
- MRKR 33.38
- ELSE 37.18
- Support Level
- MRKR $1.35
- ELSE $4.29
- Resistance Level
- MRKR $1.99
- ELSE $4.63
- Average True Range (ATR)
- MRKR 0.22
- ELSE 0.16
- MACD
- MRKR 0.01
- ELSE -0.02
- Stochastic Oscillator
- MRKR 5.21
- ELSE 17.39
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.